Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Carolyn R. Sikes"'
Publikováno v:
Clinical Therapeutics. 39:2389-2398
Purpose A new amphetamine extended-release liquid formulation (AMP XR-OS), intended for the treatment of attention-deficit/hyperactivity disorder, has been developed. This study was performed to determine if administration with food affected the rate
Publikováno v:
Journal of Attention Disorders. 24:414-419
Objective: The purpose of this study was to compare the pharmacokinetics of a new extended-release amphetamine oral suspension (AMP XR-OS) with a standard extended-release mixed amphetamine salts product, Adderall XR®. Method: In this single-dose, o
Publikováno v:
Clinical Therapeutics. 39:1695-1705
Purpose There is a strong association between attention-deficit/hyperactivity disorder (ADHD) and alcohol abuse, yet no studies have systematically assessed the effect of alcohol on the pharmacokinetics of psychostimulants such as amphetamine (AMP) i
Publikováno v:
Clinical Pharmacology in Drug Development. 7:160-167
Extended-release methylphenidate is a first-line treatment for attention-deficit/hyperactivity disorder. A methylphenidate extended-release orally disintegrating tablet (MPH XR-ODT) has recently been developed. Here we report an open-label, randomize
Publikováno v:
Journal of clinical psychopharmacology. 38(5)
A methylphenidate (MPH) extended-release orally disintegrating tablet (MPH XR-ODT) formulation was recently approved for attention-deficit/hyperactivity disorder treatment in children 6 to 17 years of age. This analysis sought to develop a population
Publikováno v:
Journal of child and adolescent psychopharmacology. 28(8)
Autor:
Andrea Marraffino, Thomas Laage, Dorothy Engelking, Andrew Volosov, Carolyn R. Sikes, Alison Hart
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 58:S292
Autor:
Alison Hart, Dorothy Engelking, Andrew Volosov, Carolyn R. Sikes, Robert A. Riesenberg, Andrea Marraffino, Thomas Laage
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 57:S173-S174
Publikováno v:
Journal of child and adolescent psychopharmacology. 28(1)
An extended-release amphetamine (AMP) oral suspension has been developed to facilitate medication ingestion and dose titration. This study sought to determine the pharmacokinetic (PK) profile of this new formulation in children with attention-deficit
Publikováno v:
Clinical pharmacology in drug development. 7(2)
Extended-release (ER) methylphenidate (MPH) is a first-line treatment for attention-deficit/hyperactivity disorder. A methylphenidate extended-release orally disintegrating tablet (MPH XR-ODT) has recently been developed. This was a randomized, open-